NCT07004296View on ClinicalTrials.gov

A Study of HDM2005 in Patients With Advanced Solid Tumor

PHASE1RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 29, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

December 1, 2027

Conditions
Advanced Solid Tumors
Interventions
DRUG

HDM2005

HDM2005 will be administered via IV infusion.

Trial Locations (1)

200032

RECRUITING

Fudan University shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

INDUSTRY